InMed Pharmaceuticals (INM) Revenue & Revenue Breakdown
InMed Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$4.94B
Latest Revenue (Q)
$1.26B
InMed Pharmaceuticals Revenue by Period
InMed Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $4.94B | 78504.30% |
| 2024-06-30 | $6.29M | 14.77% |
| 2023-06-30 | $5.48M | 290.57% |
| 2022-06-30 | $1.40M | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2012-06-30 | - | -100.00% |
| 2011-06-30 | $39.66K | -50.09% |
| 2010-06-30 | $79.46K | -52.82% |
| 2009-06-30 | $168.42K | -72.98% |
| 2008-06-30 | $623.37K | -24.51% |
| 2007-06-30 | $825.79K | -70.06% |
| 2006-06-30 | $2.76M | -34.85% |
| 2005-06-30 | $4.23M | 102.27% |
| 2004-07-31 | $2.09M | 1027.38% |
| 2003-07-31 | $185.61K | 1248.04% |
| 2002-07-31 | $13.77K | 463.84% |
| 2001-07-31 | $2.44K | - |
InMed Pharmaceuticals generated $4.94B in revenue during NA 2025, up 78504.30% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
InMed Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $1.26B | 13.48% |
| 2024-12-31 | $1.11B | 87807.13% |
| 2024-09-30 | $1.26M | -1.44% |
| 2024-06-30 | $1.28M | 9.42% |
| 2024-03-31 | $1.17M | -5.45% |
| 2023-12-31 | $1.24M | -26.60% |
| 2023-09-30 | $1.69M | -26.89% |
| 2023-06-30 | $2.31M | 123.52% |
| 2023-03-31 | $1.03M | 120.09% |
| 2022-12-31 | $469.78K | 46.45% |
| 2022-09-30 | $320.79K | -37.68% |
| 2022-06-30 | $514.76K | 66.27% |
| 2022-03-31 | $309.58K | 16.78% |
| 2021-12-31 | $265.09K | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | -100.00% |
| 2011-06-30 | $138.33 | -99.33% |
| 2011-03-31 | $20.78K | 128.68% |
| 2010-12-31 | $9.09K | 2.82% |
| 2010-09-30 | $8.84K | -82.89% |
| 2010-06-30 | $51.66K | 721.74% |
| 2010-03-31 | $6.29K | 113.95% |
| 2009-12-31 | $2.94K | -83.34% |
| 2009-09-30 | $17.64K | -41.52% |
| 2009-06-30 | $30.16K | 238.31% |
| 2009-03-31 | $8.92K | -72.88% |
| 2008-12-31 | $32.88K | -71.77% |
| 2008-09-30 | $116.48K | -118.92% |
| 2008-06-30 | $-615.65K | - |
InMed Pharmaceuticals generated $1.26B in revenue during Q3 2025, up 13.48% compared to the previous quarter, and up 101723.75% compared to the same period a year ago.